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Abstract
Lomaiviticin biosynthesis is thought to utilize a propionyl starter unit for a type II polyketide 
synthase (PKS). Discovery of the lomaiviticin (lom) biosynthetic gene cluster suggested an 
unusual method for starter unit generation involving a bifunctional acyltransferase/decarboxylase 
(AT/DC) thus far observed only in type I PKS pathways. In vitro biochemical characterization of 
AT/DC Lom62 confirmed its ability to generate a propionyl-acyl carrier protein (ACP), revealing 
a new role for this enzymatic activity within natural product biosynthesis.
Aromatic polyketides are an important family of natural products that includes clinically 
used antibiotics and antitumor agents.1 These secondary metabolites are constructed from 
malonate building blocks using iterative decarboxylative Claisen condensations carried out 
by a type II polyketide synthase (PKS). An important point for introducing structural 
diversity in these pathways is the initial priming of the PKS with a starter unit.3 
Understanding the logic underlying starter unit synthesis is therefore a critical component of 
efforts to engineer the biosynthesis of ‘non-natural’ analogs of aromatic polyketides.4 Here 
we detail evidence supporting the involvement of a new strategy for starter unit generation 
in lomaiviticin biosynthesis that employs an enzyme previously associated only with type I 
modular PKSs.
Type II PKS systems consist of a ketosynthase-chain length factor (KSα-CLF) complex, 
which performs the C–C bond-forming chemistry, and an acyl carrier protein (ACP) that 
tethers an incoming malonyl extender unit. The acyltransferase (AT) that selects and loads 
malonyl-coenzyme A (CoA) is shared with fatty acid synthesis.2 The majority of secondary 
metabolites made by type II PKS systems utilize an acetate starter unit generated by 
decarboxylation of a malonyl-ACP thioester substrate derived from malonyl-CoA.5 
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Propionyl starter units are employed less frequently, but are involved in the biosynthesis of 
the clinically important anti-tumor drugs doxorubicin (1a) and daunorubicin (1b) (Figure 
1A).6 To date, all characterized mechanisms for incorporating propionyl starter units into 
type II polyketides utilize propionyl-CoA as the source of this three carbon building block. 
In doxorubicin/daunorubicin biosynthesis, a separate priming KS (KSIII), homologous to 
the E. coli FabH enzyme, catalyzes an initial Claisen condensation using propionyl-CoA and 
ACP-bound malonyl-CoA (Figure 1B).6 The diketide product is then transferred to the main 
KSα-CLF for further rounds of elongation. Other type II polyketide biosynthetic pathways 
that utilize longer alkyl chain starter units similarly employ this KSIII loading module 
strategy,7 and most of the corresponding gene clusters also encode a second ACP that is 
dedicated to starter unit production.7c
The lomaiviticins (2) and kinamycins (3) are two families of diazo-containing aromatic 
polyketides that have attracted attention from both synthetic and biological chemists (Figure 
2).8 Though these metabolites possess considerable structural similarity, a key difference 
between them is the D-ring alkyl substituent, which likely arises from use of distinct type II 
PKS starter units. The kinamycin PKS is predicted to use a canonical acetate starter unit, 
resulting in a D-ring methyl group. In contrast, substitution of an ethyl group at the 
corresponding position of the lomaiviticin scaffold suggests use of a propionyl starter unit. 
Recently, Moore and co-workers discovered a lomaiviticin (lom) biosynthetic gene cluster in 
the marine actinomycete Salinispora tropica CNB-440.9 We have also identified a 
homologous biosynthetic gene cluster in the lomaiviticin producer Salinispora pacifica 
DPJ-0019.10 Unexpectedly, neither cluster encoded an enzyme homologous to the priming 
KSIII typically employed in propionyl starter unit loading.9 The absence of this enzymatic 
function suggested that an alternate method of starter unit synthesis could be used in 
lomaiviticin biosynthesis.
In our cluster annotation we identified several genes that we hypothesized could play roles 
in propionyl starter unit generation: a homolog of the bifunctional acyltransferase/
decarboxylase (AT/DC) LnmK (lom62) and two ACPs (lom60 and lom63). LnmK is 
involved in the biosynthesis of leinamycin (3), a natural product constructed by a type I 
modular PKS-nonribosomal synthetase (NRPS) assembly line (Figure 3A). Biochemical 
characterization of LnmK has revealed its ability to catalyze both transfer of methylmalonyl-
CoA to an ACP and subsequent decarboxylation to provide a propionyl-ACP thioester.11 
This intermediate is ultimately utilized to install a β-propionyl substituent onto the 
polyketide backbone of leinamycin during chain elongation (Figure 3B).12-14 Recently, the 
crystal structure of LnmK was solved.15 Co-crystallization with methylmalonyl-CoA 
revealed putative active site residues, which led to the identification of an essential tyrosine 
(Tyr62) as the key functionality necessary for AT activity. Homologs of LnmK have been 
noted in other gene clusters encoding type I PKS-NRPS pathways, including the 
myxovirescin A (5) gene cluster.11
The presence of an LnmK homolog (44% amino acid identity, 60% similarity) in the lom 
gene cluster led us to hypothesize that Lom62 might catalyze an analogous reaction, 
transferring methylmalonyl-CoA to an ACP and then decarboxylating the resulting 
methylmalonyl-ACP thioester intermediate to generate a propionyl-ACP thioester (Figure 
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3C). Transfer of this propionyl starter unit to the KS domain of the KSα-CLF could then 
occur directly from the ACP or via the action of predicted AT Lom61. The presence of two 
ACPs in the lom cluster (Lom 60 and Lom 63) further suggests use of an alternate starter 
unit, with one of the ACPs likely dedicated to propionyl-ACP generation. Importantly, 
homologs of these enzymes (Lom62 and a second ACP) are not found in the kinamycin 
biosynthetic gene cluster,16 providing additional support for this hypothesis. If operative, 
this co-opting of type I PKS tailoring enzymes would constitute a completely new 
mechanism for type II PKS starter unit generation. However, the dramatically different 
pathway contexts of Lom62 and LnmK (type II vs. type I modular PKS systems) precluded 
the assumption that the two enzymes would exhibit the same biochemical activity.
To verify that the sequence similarity of Lom62 and LnmK was likely to reflect a shared 
biochemical function, we performed additional bioinformatic analyses. Alignment of the 
two amino acid sequences showed conservation of the essential tyrosine residue that is 
hypothesized to function as the nucleophile in catalysis (Figure S9). Key residues that 
contact the CoA backbone are also conserved in Lom62. These similarities were reinforced 
by construction of a Lom62 homology model (Figure S11). Overall, these analyses 
confirmed that Lom62 and LnmK might possess related functions.
We tested the hypothesis that Lom62 plays a role in propionyl starter unit generation by 
characterizing its activity in vitro. We cloned lom62 and the two ACPs lom60 and lom63 
from S. pacifica DPJ-0019 and expressed them individually in E. coli as His6-tagged 
fusions. Analysis of LC-MS data confirmed the identities of both apo-ACPs and their ability 
to undergo conversion to their corresponding holo-forms in the presence of CoA and the 
phosphopantethienyltransferase Sfp (Figures S2-S8, Tables S2-S4).17 We examined the 
activity of Lom62 toward each holo-ACP in the presence of potential substrates 
methylmalonyl-CoA and propionyl-CoA using an HPLC assay (Figure 4A). LC-MS analysis 
verified the identities of the major products (Tables S5 and S6). Robust, Lom62-dependent 
formation of the expected propionyl-ACP thioester product was observed only in the 
presence of methylmalonyl-CoA and Lom63. In comparison, reactions of Lom62 with 
methylmalonyl-CoA and alternate ACP Lom60 were sluggish, providing <10% conversion 
after 1 h. Lom62 was not able to generate propionyl-ACP product from propionyl-CoA in 
combination with either ACP partner, confirming that decarboxylation takes place after 
loading.
To further explore the specificity of Lom62 for the two ACPs, we performed a competition 
experiment, incubating equal concentrations (43 μM) of the two ACPs with methylmalonyl-
CoA and Lom62 for 1 h (Figure 4C). Under these conditions we observed almost exclusive 
formation of propionyl-Lom63 by HPLC analysis. This result suggests that LnmK 
preferentially interacts with only one of the two ACPs encoded in the lomaiviticin cluster. 
The use of a dedicated ACP for starter unit generation is also observed for other priming 
mechanisms that use non-acetate type II PKS starter units.7c Overall, these biochemical 
experiments support our hypothesis that Lom62 is involved in generating the propionyl 
starter unit required for lomaiviticin biosynthesis and reveal Lom63 as its partner ACP. 
Additional biochemical experiments are needed to elucidate the precise mechanism of 
propionyl starter unit transfer to the type II PKS.
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The potential distribution of this alternate propionyl starter unit synthesis machinery across 
other type II PKS biosynthetic pathways was evaluated by searching for homologs of 
Lom62 in sequenced bacterial genomes (Table S8). The majority of the most closely related 
enzymes were part of other lom clusters (32 hits). However, we found 11 Lom62/LnmK 
homologs that were were co-localized with genes encoding type I PKS assembly lines and 
other enzymes involved in β-alkyl installation,14 and an additional two homologs located 
near type II PKS biosynthetic machinery that was distinct from the lom gene cluster. This 
analysis suggests that the decarboxylative route to propionyl starter unit generation is 
utilized by other type II PKS systems. We hypothesize that this priming strategy could have 
evolved in response to differences in the availability of methylmalonyl-CoA and propionyl-
CoA precursors in producing organisms.
In summary, we have discovered that a new mechanism for type II PKS propionyl starter 
unit generation may be operative in lomaiviticin biosynthesis. Intriguingly, this process co-
opts enzymes previously associated only with type I PKS pathways. These experiments are 
the first step towards understanding the logic underlying this unique priming strategy, which 
may represent a new target for metabolic engineering efforts targeting aromatic polyketide 
biosynthesis.
Supplementary Material
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Figure 1. 
Propionyl starter units are employed in aromatic polyketide biosynthesis. A) Natural 
products made by type II polyketide synthases (PKSs) that utilize a propionyl starter unit. B) 
Characterized pathway for type II PKS priming with a propionyl starter unit.
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Figure 2. 
The lomaiviticin and kinamycin families of aromatic polyketides likely use different starter 
units in biosynthesis.
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Figure 3. 
An enzyme involved in type I PKS biosynthesis may be utilized in lomaiviticin starter unit 
generation. A) Natural products synthesized by type I PKS-nonribosomal peptide synthetase 
assembly lines contain β-propionyl and -ethyl branching. B) Role of acyltransferase/
decarboxylase (AT/DC) LnmK in leinamycin biosynthesis. C) Hypothesized role of LnmK 
homolog Lom62 in lomaiviticin biosynthesis.
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Figure 4. 
Lom62 generates a propionyl-ACP intermediate from methylmalonyl-CoA for potential use 
as starter unit in lomaiviticin biosynthesis. A) HPLC assays of Lom62 with holo-acyl carrier 
proteins Lom63 and Lom60 (1 h time point) demonstrate loading and decarboxylation of 
methylmalonyl-CoA to generate propionyl-ACPs and a preference for Lom63. UV detection 
(220 nm). B) Deconvoluted mass spectrum of the Lom62 + Lom63 mMal-CoA full reaction 
assay. C) HPLC competition assay with equal amounts of ACPs (1 h time point) reveals 
selective generation of propionyl-Lom63. UV detection (220 nm). Abbreviations: ACP = 
acyl carrier protein, AT = acyltransferase, mMal-CoA = methylmalonyl-CoA, prop-CoA = 
propionyl-CoA.
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